NEW YORK (GenomeWeb News) — As Solexa and Applied Biosystems prepare to roll out their next-generation sequencers, investors are getting curious about how they will compete against each other and where each might have an edge.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.